IRIS Accounts Production v26.1.10.61 09171173 director 1.9.24 31.8.25 31.8.25 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091711732024-08-31091711732025-08-31091711732024-09-012025-08-31091711732023-08-31091711732023-09-012024-08-31091711732024-08-3109171173ns15:EnglandWales2024-09-012025-08-3109171173ns14:PoundSterling2024-09-012025-08-3109171173ns10:Director12024-09-012025-08-3109171173ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3109171173ns10:Micro-entities2024-09-012025-08-3109171173ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3109171173ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3109171173ns10:FullAccounts2024-09-012025-08-3109171173ns5:CurrentFinancialInstruments2025-08-3109171173ns5:CurrentFinancialInstruments2024-08-3109171173ns5:Non-currentFinancialInstruments2025-08-3109171173ns5:Non-currentFinancialInstruments2024-08-3109171173ns10:RegisteredOffice2024-09-012025-08-3109171173ns10:Director112024-08-3109171173ns10:Director112023-08-3109171173ns10:Director112024-09-012025-08-3109171173ns10:Director112023-09-012024-08-3109171173ns10:Director112025-08-3109171173ns10:Director112024-08-31
REGISTERED NUMBER: 09171173 (England and Wales)










Financial Statements

for the Year Ended 31 August 2025

for

QPharma Services Limited

QPharma Services Limited (Registered number: 09171173)

Contents of the Financial Statements
for the Year Ended 31 August 2025










Page

Balance Sheet 1


QPharma Services Limited (Registered number: 09171173)

Balance Sheet
31 August 2025

31.8.25 31.8.24
£    £    £    £   
Fixed assets 1 1

Current assets 408,043 467,877

Creditors
Amounts falling due within one year (25,527 ) (69,280 )
Net current assets 382,516 398,597
Total assets less current liabilities 382,517 398,598

Creditors
Amounts falling due after more than one
year

(39,970

)

(39,970

)
Net assets 342,547 358,628

Capital and reserves 342,547 358,628

Notes to the financial statements

1. Statutory information

QPharma Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09171173

Registered office: 14 Wainwright Avenue
Hamilton
Leicester
LE5 1QW

The presentation currency of the financial statements is the Pound Sterling (£).


2. Average number of employees

The average number of employees during the year was 1 (2024 - 1 ) .

QPharma Services Limited (Registered number: 09171173)

Balance Sheet - continued
31 August 2025

Notes to the financial statements

3. Director's advances, credits and guarantees

The following advances and credits to a director subsisted during the years ended 31 August 2025 and 31 August 2024:

31.8.25 31.8.24
£    £   
P R Patel
Balance outstanding at start of year 313,272 454,086
Amounts advanced 39,111 361
Amounts repaid (44,885 ) (141,175 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 307,498 313,272



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 26 May 2026 and were signed by:





P R Patel - Director